Documentos relacionados

1. Simvastatin attenuates the c-Raf/Erk and calcineurin-NFATc2 pathways via inhibition of Hsp90 activity during the development of heart failure.
2. Therapeutic Effects of Lipid Lowering Medications on Myocardial Blood Flow, Inflammation, and Sympathetic Nerve Activity Using Nuclear Techniques.
3. Statins in Patients With Established Heart Failure: Time for Reflection.
4. Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-ß Signaling.
5. Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives.
6. Expanding the Substrate Scope of Acyltransferase LovD9 for the Biosynthesis of Statin Analogues.
7. PCSK9 Inhibition in Patients After Heart Transplantation: a Retrospective Review and Literature Analysis.
8. Statin Lipophilicity and the Risk of Incident Heart Failure.
9. Effect of statin treatment on the risk of cancer in patients with heart failure: A target trial emulation study.
10. Alirocumab after acute coronary syndrome in patients with a history of heart failure.